Skip to content
Open access · CC-BY via OpenAlex

Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice

Edward Fielder, Tengfei Wan, Ghazaleh Alimohammadiha, Abbas Ishaq, Evon Low, B. Melanie Weigand, George Kelly, Craig Parker, Brigid Griffin, Diana Jurk, Viktor I. Korolchuk, Thomas von Zglinicki, Satomi Miwa

eLife · 2022 · ▲ 73 citations

Abstract

Cancer survivors suffer from progressive frailty, multimorbidity, and premature morbidity. We hypothesise that therapy-induced senescence(definition) and senescence progression via bystander effects are significant causes of this premature ageing phenotype. Accordingly, the study addresses the question whether a short anti-senescence intervention is able to block progression of radiation-induced frailty and disability in a pre-clinical setting. Male mice were sublethally irradiated at 5 months of age and treated (or not) with either a senolytic drug (Navitoclax or dasatinib + quercetin) for 10 days or with the senostatic metformin for 10 weeks. Follow-up was for 1 year. Treatments commencing within a month after irradiation effectively reduced frailty progression (p<0.05) and improved muscle (p<0.01) and liver (p<0.05) function as well as short-term memory (p<0.05) until advanced age with no need for repeated interventions. Senolytic interventions that started late, after radiation-induced premature frailty was manifest, still had beneficial effects on frailty (p<0.05) and short-term memory (p<0.05). Metformin was similarly effective as senolytics(definition). At therapeutically achievable concentrations, metformin acted as a senostatic neither via inhibition of mitochondrial complex I, nor via improvement of mitophagy or mitochondrial function, but by reducing non-mitochondrial reactive oxygen species production via NADPH oxidase 4 inhibition in senescent cells. Our study suggests that the progression of adverse long-term health and quality-of-life effects of radiation exposure, as experienced by cancer survivors, might be rescued by short-term adjuvant anti-senescence interventions.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.7554/elife.75492
Canonical
link ↗
Fetched
2026-11-04 MST

Cite this

APA
Fielder, E., Wan, T., Alimohammadiha, G., Ishaq, A., Low, E., Weigand, B.M., Kelly, G., Parker, C., Griffin, B., Jurk, D., Korolchuk, V.I., Zglinicki, T.V., &amp; Miwa, S. (2022). Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice. <em>eLife</em>. https://doi.org/10.7554/elife.75492
Vancouver
Fielder E, Wan T, Alimohammadiha G, Ishaq A, Low E, Weigand BM, et al. Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice. eLife. 2022. doi:10.7554/elife.75492.
BibTeX
@article{edward2022Shorts, title = {Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice}, author = {Edward Fielder and Tengfei Wan and Ghazaleh Alimohammadiha and Abbas Ishaq and Evon Low and B. Melanie Weigand and George Kelly and Craig Parker and Brigid Griffin and Diana Jurk and Viktor I. Korolchuk and Thomas von Zglinicki and Satomi Miwa}, journal = {eLife}, year = {2022}, doi = {10.7554/elife.75492}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings